Insider Transactions in Q2 2024 at Seres Therapeutics, Inc. (MCRB)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 15
2024
|
Lisa Von Moltke |
SELL
Open market or private sale
|
Direct |
939
-4.71%
|
$0
$0.94 P/Share
|
|
May 15
2024
|
Lisa Von Moltke |
BUY
Exercise of conversion of derivative security
|
Direct |
2,968
+12.95%
|
-
|
|
May 15
2024
|
Thomas Des Rosier Chief Legal Officer and EVP |
SELL
Open market or private sale
|
Direct |
843
-0.68%
|
$0
$0.94 P/Share
|
|
May 15
2024
|
Thomas Des Rosier Chief Legal Officer and EVP |
BUY
Exercise of conversion of derivative security
|
Direct |
2,656
+2.11%
|
-
|
|
May 15
2024
|
David S. Ege |
SELL
Open market or private sale
|
Direct |
1,090
-1.42%
|
$0
$0.94 P/Share
|
|
May 15
2024
|
David S. Ege |
BUY
Exercise of conversion of derivative security
|
Direct |
2,968
+3.72%
|
-
|
|
May 15
2024
|
Matthew R. Henn |
SELL
Open market or private sale
|
Direct |
891
-1.34%
|
$0
$0.94 P/Share
|
|
May 15
2024
|
Matthew R. Henn |
BUY
Exercise of conversion of derivative security
|
Direct |
2,812
+4.07%
|
-
|
|
May 15
2024
|
Teresa L. Young |
SELL
Open market or private sale
|
Direct |
703
-3.83%
|
$0
$0.94 P/Share
|
|
May 15
2024
|
Teresa L. Young |
BUY
Exercise of conversion of derivative security
|
Direct |
2,656
+12.64%
|
-
|
|
May 15
2024
|
Eric D. Shaff CEO and President |
SELL
Open market or private sale
|
Direct |
2,435
-1.7%
|
$0
$0.94 P/Share
|
|
May 15
2024
|
Eric D. Shaff CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
7,812
+5.18%
|
-
|